FDA Posts Proposed Rule on GRAS: What We Know So Far
The FDA has posted an outline of a proposed rule to require the mandatory submission of Generally Recognized as Safe (GRAS) notices. If finalized, the rule would effectively eliminate self-affirmed GRAS without notification—long criticized for its lack of transparency—by requiring companies to notify the FDA and be listed in a public-facing register. Substances already listed […]